首页> 外文OA文献 >PDB57 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE 1 DIABETES PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN IN GERMANY

【2h】

PDB57 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE 1 DIABETES PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN IN GERMANY

机译：PDB57含胰岛素甘草糖的较低治疗费用与德国基础-博古斯疗法治疗的1型糖尿病患者的胰岛素含量相比

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wiesner T; Schädlich PK; Dippel FW; Koltermann K; Hagenmeyer EG;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes. [J] . Hollander P, Cooper J, Bregnhoj J, Clinical therapeutics . 2008,第11期

机译：一项为期52周的跨国，开放标签，平行分组，非劣效，以治疗为目标的试验，比较了在2型糖尿病患者中，在就餐时使用了门冬胰岛素治疗的基础大剂量方案中，将地特米与甘精胰岛素进行比较。
2. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial. [J] . Heller S, Koenen C, Bode B Clinical therapeutics . 2009,第10期

机译：在1型糖尿病患者的基础推注方案中，以门冬胰岛素作为进餐时胰岛素对地特胰岛素和甘精胰岛素的比较：52周，多国，随机，开放标签，平行分组，按治疗目标非劣效性试验。
3. Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany [J] . Stefan Pscherer, Eva Susanne Dietrich, Franz-Werner Dippel, German Medical Science . 2010,第3期

机译：德国将甘精胰岛素和地特胰岛素联合进餐时服用门冬胰岛素的基础推注方案的成本比较
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany [O] . Stefan Pscherer, Eva Susanne Dietrich, Franz-Werner Dippel, 2010

机译：德国将甘精胰岛素与地特美胰岛素在基础推注方案中进餐时服用门冬胰岛素的成本比较
7. PDB35 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE-2 DIABETES PATIENTS ON BASAL-BOLUS THERAPY UNDER REAL WORLD CONDITIONS IN GERMANY [O] . Bierwirth R, Kohlmann T, Dippel FW, 2009

机译：在现实世界中，德国对基底静脉输注治疗的2型糖尿病患者中的PDB35含胰岛素甘露聚糖的治疗费用与胰岛素DETEMIR的比较

PDB57 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE 1 DIABETES PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN IN GERMANY

著录项

引文网络

相似文献

相关主题

期刊订阅